USPCM
CEMI

Union Square Park Capital Management’s Chembio diagnostics, Inc. CEMI Stock Holding History

Union Square Park Capital Management’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-75,000
Closed -$263K – 115
2021
Q1 		$263K Sell
75,000
-325,000
-81% -$1.81M 0.09% 79
2020
Q4 		$1.9M Buy
+400,000
New +$2.07M 0.76% 33

Other funds holding CEMI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TEE
Tibra Equities Europe London, United Kingdom $90.4M AUM 37.81% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Union Square Park Capital Management's CEMI Position: Q2 2021 in Review

Union Square Park Capital Management sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2021, closing a stake of 75,000 shares — an estimated $263K sold.

Union Square Park Capital Management first reported a position in CEMI in Q4 2020 and held it in 2 quarters. The position peaked at $1.9M in Q4 2020. 60 funds tracked by Wall St. Rank hold CEMI as of Q2 2021.

  • Union Square Park Capital Management reported no remaining Chembio diagnostics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Union Square Park Capital Management sold 75,000 Chembio diagnostics, Inc. shares in Q2 2021, an estimated $263K.
  • Union Square Park Capital Management first reported a position in Chembio diagnostics, Inc. in Q4 2020 and held it in 2 quarters.
  • Union Square Park Capital Management's Chembio diagnostics, Inc. position peaked at $1.9M in Q4 2020.
  • 60 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2021.

Based on Union Square Park Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.